Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11

The prognostic impact of KIT mutation on core-binding factor acute myeloid leukemia (CBF-AML) remains controversial. We registered 199 newly diagnosed de novo CBF-AML patients, aged 16 to 64 years, who achieved complete remission. They received 3 courses of high-dose cytarabine therapy and no furthe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood Adv
Asıl Yazarlar: Ishikawa, Yuichi, Kawashima, Naomi, Atsuta, Yoshiko, Sugiura, Isamu, Sawa, Masashi, Dobashi, Nobuaki, Yokoyama, Hisayuki, Doki, Noriko, Tomita, Akihiro, Kiguchi, Toru, Koh, Shiro, Kanamori, Heiwa, Iriyama, Noriyoshi, Kohno, Akio, Moriuchi, Yukiyoshi, Asada, Noboru, Hirano, Daiki, Togitani, Kazuto, Sakura, Toru, Hagihara, Maki, Tomikawa, Tatsuki, Yokoyama, Yasuhisa, Asou, Norio, Ohtake, Shigeki, Matsumura, Itaru, Miyazaki, Yasushi, Naoe, Tomoki, Kiyoi, Hitoshi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2020
Konular:
Myeloid Neoplasia
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6960455/
https://ncbi.nlm.nih.gov/pubmed/31899799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000709
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller